|
Market Closed -
Bombay S.E.
11:02:27 25/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 10.10 INR | -0.49% |
|
-1.66% | -29.37% |
| Market Cap | 2.45B 25.6M 22.47M 21.22M 19.34M 36.2M 36.45M 254M 98.34M 1.25B 96.12M 94.04M 4.03B | P/E 2025 |
15.4x | P/E 2026 | 8.26x |
|---|---|---|---|---|---|
| Enterprise Value | 2.87B 29.98M 26.31M 24.84M 22.64M 42.38M 42.69M 297M 115M 1.47B 113M 110M 4.72B | EV / Sales 2025 |
1.79x | EV / Sales 2026 | 1.25x |
| Free-Float |
63.52% | Yield 2025 * |
-
| Yield 2026 | - |
| 1 day | -0.49% | ||
| 1 week | -1.66% | ||
| Current month | -19.97% | ||
| 1 month | -16.67% | ||
| 3 months | -5.78% | ||
| 6 months | +18.68% | ||
| Current year | -29.37% |
| 1 week | 10.01 | 10.65 | |
| 1 month | 10 | 13.25 | |
| Current year | 7.05 | 14.77 | |
| 1 year | 7.05 | 17.25 | |
| 3 years | 7.05 | 29 | |
| 5 years | 4.81 | 29 | |
| 10 years | 1.32 | 29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Arihant Baid
CEO | Chief Executive Officer | 40 | 17/05/2012 |
| Director of Finance/CFO | - | 11/11/2024 | |
| Compliance Officer | 62 | 19/04/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Arihant Baid
CHM | Chairman | 40 | - |
| Director/Board Member | - | 20/12/2020 | |
| Director/Board Member | - | 20/12/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.49% | -1.66% | -14.48% | +23.77% | 25.6M | ||
| +0.13% | +2.65% | +63.34% | +115.17% | 1,055B | ||
| +0.20% | +0.46% | +50.92% | +70.56% | 654B | ||
| -0.29% | +0.14% | +19.82% | +71.75% | 467B | ||
| -0.85% | +0.98% | +42.13% | +44.64% | 348B | ||
| +0.71% | +4.08% | +21.75% | +28.83% | 275B | ||
| +1.23% | +0.42% | +14.11% | +12.43% | 258B | ||
| +2.11% | +7.51% | +51.88% | +54.11% | 224B | ||
| +0.83% | +0.55% | +34.64% | +99.83% | 187B | ||
| 0.00% | -10.14% | -27.40% | -61.08% | 171B | ||
| Average | +0.36% | +0.50% | +25.67% | +46.00% | 363.84B | |
| Weighted average by Cap. | +0.27% | +1.32% | +40.43% | +68.21% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 1.38B 14.39M 12.63M 11.92M 10.87M 20.34M 20.49M 143M 55.27M 705M 54.02M 52.85M 2.26B | 1.73B 18.02M 15.82M 14.94M 13.61M 25.48M 25.66M 179M 69.23M 882M 67.67M 66.21M 2.84B |
| Net income | 181M 1.89M 1.66M 1.57M 1.43M 2.67M 2.69M 18.75M 7.26M 92.58M 7.1M 6.95M 298M | 210M 2.19M 1.92M 1.81M 1.65M 3.09M 3.12M 21.71M 8.41M 107M 8.22M 8.04M 344M |
| Net Debt | -275M -2.87M -2.52M -2.38M -2.17M -4.05M -4.08M -28.43M -11.01M -140M -10.76M -10.53M -451M | 420M 4.38M 3.84M 3.63M 3.31M 6.19M 6.23M 43.41M 16.81M 214M 16.43M 16.08M 689M |
Employees
125
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 25/09/26 | ₹10.10 | -0.49% | 195,686 |
| 24/09/26 | ₹10.15 | -1.65% | 166,542 |
| 23/09/26 | ₹10.32 | +1.08% | 151,130 |
| 22/09/26 | ₹10.21 | -0.68% | 112,122 |
| 21/09/26 | ₹10.28 | +0.10% | 315,294 |
- Stock Market
- Stocks
- GENNEX6 Stock
Select your edition
All financial news and data tailored to specific country editions
















